MMMarsha A. Moses

Marsha A. Moses

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marsha A. Moses has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Iinmin Wu

    Vascular Biology Program, Children's Hospital Boston and

    1 shared publication
  • Jay Harper

    Vascular Biology Program, Children's Hospital Boston, Department of Surgery, Harvard Medical School, Boston, Massachusetts, USA

    1 shared publication
  • Jianmin Fang

    Department of Preclinical Oncology and Immunology, Cell Genesys, Inc., San Francisco, California

    1 shared publication
  • Li Yan

    Oncology Research, Centocor R&D, Inc., Malvern, Pennsylvania; and

    1 shared publication
  • Patricia A. D'AMore

    Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, 02114, USA

    1 shared publication
  • Robyn M. Loureiro

    Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts

    1 shared publication

Latest Publications

  • Open Access

    Repression of Vascular Endothelial Growth Factor Expression by the Zinc Finger Transcription Factor ZNF24

    by Jay Harper, Li Yan, Robyn M. Loureiro, Iinmin Wu, Jianmin Fang, Patricia A. D'AMore, Marsha A. Moses

    Vascular endothelial growth factor (VEGF) is a potent stimulator of angiogenesis. Although many positive regulators of VEGF have been identified, relatively little is known regarding the negative regulation of VEGF expression. We identified a zinc finger transcription factor, ZNF24, that may repress VEGF transcription. An inverse correlation between expression of VEGF and ZNF24 was observed in a series of independent studies. ZNF24 was up-regulated in angiogenic tumor nodules where VEGF expression is significantly decreased compared with preangiogenic nodules. In human breast carcinoma cells cultured under normoxic conditions, ZNF24 levels were significantly up-regulated whereas VEGF levels were low. In contrast, VEGF was significantly increased in hypoxic cells whereas ZNF24 was down-regulated. The same inverse correlation between ZNF24 and VEGF was also observed in 70% of matched cDNA pairs of normal and malignant tissues from human colon and breast biopsies. Overexpression of ZNF24 resulted in a significant down-regulation of VEGF, whereas silencing of ZNF24 with small interfering RNA led to increased VEGF expression. Cotransfection of ZNF24 and a VEGF promoter luciferase reporter construct in MDA-MB-231 cells resulted in a significant decrease in VEGF promoter activity. Taken together, these data suggest that ZNF24 is involved in negative regulation of VEGF and may represent a novel repressor of VEGF transcription. [Cancer Res 2007;67(18):8736–41]